Medicure (MCUJF) Asset Writedowns and Impairment (2009 - 2020)

Medicure (MCUJF) recorded quarterly Asset Writedowns and Impairment of $284577.3 in Q4 2020, up 279.41% quarter-over-quarter from $75005.2 in Q2 2020, and down 93.46% on a YoY basis from $4.4 million in Q1 2020.

Medicure (MCUJF) Asset Writedowns and Impairment (2009 - 2020) Analysis & Trends

Medicure's Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $284577.3 for Q4 2020.

  • In Q4 2020, Asset Writedowns and Impairment fell 93.46% year-over-year to $284577.3; the TTM figure through Dec 2020 stood at $513982.7 (down 86.16% YoY), while the FY2023 annual figure was $205303.1, up 633.36% from the prior year.
  • Asset Writedowns and Impairment was $284577.3 for Q4 2020 at Medicure, up from $75005.2 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.4 million in Q4 2019 to a low of $75005.2 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Medicure - - 2.57 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 284,577.28
Dec 31, 2020 284,577.28
Jun 30, 2020 75,005.21
Jun 30, 2020 75,005.21
Mar 31, 2020 154,400.18
Mar 31, 2020 154,400.18
Dec 31, 2019 4.35 Mn
Dec 31, 2019 4.35 Mn
Dec 31, 2015 -662,817.57
Dec 31, 2015 -662,817.57
Sep 30, 2015 5,493.69
Sep 30, 2015 5,493.69
Aug 31, 2014 20,518.62
Aug 31, 2014 20,518.62
May 31, 2014 20,191.76
May 31, 2014 20,191.76
Aug 31, 2012 6,094.88
Aug 31, 2012 6,094.88
May 31, 2010 695,113.35
May 31, 2010 695,113.35